BMS-986179

BMS-986179 is a human monoclonal antibody (mAb) targeting NT5E/CD73. BMS-986179 inhibits CD73 enzymatic activity in tumor vasculature and tumor cells. BMS-986179 can be used in advanced solid tumors research[1].

Product Specifications

UNSPSC

12352203

Target

CD73

Related Pathways

Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Smiles

[BMS-986179]

References & Citations

[1]Siu L L, et al. Abstract CT180: Preliminary phase 1 profile of BMS-986179, an anti-CD73 antibody, in combination with nivolumab in patients with advanced solid tumors[J]. Cancer Research, 2018, 78 (13_Supplement) : CT180-CT180.